Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules

scientific article published on May 1996

Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1996PNAS...93.4583B
P356DOI10.1073/PNAS.93.10.4583
P932PMC publication ID39320
P698PubMed publication ID8643447
P5875ResearchGate publication ID14558011

P2093author name stringWiley DC
Bouvier M
P2860cites workThe antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2Q27729917
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigenQ27731278
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalaseQ28257553
Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigenQ34727706
Naturally processed heterodimeric disulfide-linked insulin peptides bind to major histocompatibility class II molecules on thymic epithelial cellsQ35206214
Molecular components of T-cell recognitionQ36135284
Pegylated peptides. II. Solid-phase synthesis of amino-, carboxy- and side-chain pegylated peptidesQ36752051
HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptidesQ36954248
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.Q39392898
Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant ConjugatesQ40437361
The three-dimensional structure of peptide-MHC complexesQ40444937
Importance of peptide amino and carboxyl termini to the stability of MHC class I moleculesQ43655210
Presentation of three different viral peptides, HTLV-1 Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule.Q44200360
Synthesis of cyclic peptides on solid support. Application to analogs of hemagglutinin of influenza virusQ44499137
Ligand recognition by influenza virus. The binding of bivalent sialosidesQ44975303
Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC moleculeQ46768053
Color test for detection of free terminal amino groups in the solid-phase synthesis of peptidesQ56390180
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigensQ59092174
The monitoring of reactions in solid-phase peptide synthesis with picric acidQ70446545
Proline-specific endopeptidase from Flavobacterium. Purification and propertiesQ71500866
Antigenic peptide binding by class I and class II histocompatibility proteinsQ72192298
A new procedure for the synthesis of polyethylene glycol-protein adducts; Effects on function, receptor recognition, and clearance of superoxide dismutase, lactoferrin, and α2-macroglobulinQ72711204
A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I moleculesQ73909504
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)4583-4588
P577publication date1996-05-01
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleAntigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules
P478volume93

Reverse relations

cites work (P2860)
Q35864562Assemblons: nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus 1
Q38331811Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705.
Q36082074Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease.
Q51626103Cyclodimerization of immunosuppressive fragment of HLA-DR molecule. Design, synthesis and ESI-MS/MS analysis.
Q52528201Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue.
Q77713303From peptides to peptidomimetics: design of nonpeptide ligands for major histocompatibility proteins
Q41353115MHC class I and class II structures
Q41605278Peptide binding by class I and class II MHC molecules
Q37844539Peptidomimetics: modifying peptides in the pursuit of better vaccines
Q74546450Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer
Q47828186Substituting nonpeptidic spacers for the T cell receptor-binding part of class I major histocompatibility complex-binding peptides.
Q33965271The benefits and challenges associated with the use of drug delivery systems in cancer therapy

Search more.